Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 43 | 0 | 3 | 0 | €720.50 | €759.34 | 5.390% |
Alnylam Pharmace. | 34 | 0 | 3 | 0 | €138.40 | €236.30 | 70.736% |
Vertex Pharmaceuticals Inc. | 36 | 2 | 1 | 0 | €387.75 | €382.71 | -1.301% |
Boston Scientific | 33 | 0 | 0 | 0 | €63.44 | €60.31 | -4.939% |
Intuitive Surgical Inc | 33 | 0 | 4 | 0 | €370.00 | €370.00 | 0.000% |
Regeneron Pharmaceuticals Inc. | 31 | 1 | 3 | 0 | €890.50 | €944.73 | 6.090% |
Johnson & Johnson | 30 | 1 | 2 | 1 | €146.60 | €196.36 | 33.942% |
UnitedHealth Group Inc. | 28 | 1 | 1 | 0 | €456.50 | €546.89 | 19.801% |
Merck & Co. Inc. | 27 | 1 | 3 | 1 | €122.40 | €124.85 | 2.006% |
Pfizer Inc. | 28 | 4 | 3 | 1 | €25.75 | €40.22 | 56.179% |
Thermo Fisher Scientific Inc. | 24 | 0 | 1 | 0 | €538.20 | €558.84 | 3.835% |
Cytokinetics Inc. | 24 | 1 | 6 | 0 | €65.00 | €86.72 | 33.408% |
Neurocrine Bioscience | 21 | 0 | 3 | 0 | €128.00 | €136.69 | 6.791% |
Edwards Lifesciences Corp. | 22 | 1 | 2 | 0 | €88.56 | €88.15 | -0.459% |
Acadia Pharmaceuticals | 20 | 0 | 8 | 0 | €16.90 | €32.44 | 91.931% |
Amgen Inc. | 20 | 0 | 0 | 0 | €263.80 | €291.23 | 10.399% |
Tenet Healthcare | 20 | 0 | 2 | 0 | €97.00 | €95.79 | -1.243% |
Intra-Cellular Therapies Inc. | 19 | 0 | 0 | 0 | €64.10 | €75.68 | 18.062% |
Zoetis Inc. A | 19 | 0 | 0 | 0 | €156.80 | €200.06 | 27.588% |
R1 RCM Inc. | 18 | 0 | 5 | 0 | €12.00 | €17.02 | 41.795% |
AbbVie Inc. | 18 | 0 | 2 | 0 | €168.70 | €175.79 | 4.202% |
BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €81.00 | €102.48 | 26.514% |
Pro-Dex Inc. | 17 | 0 | 0 | 0 | €15.40 | - | - |
Natural Alternat. | 18 | 1 | 2 | 1 | €5.45 | - | - |
HCA Holdings Inc. | 17 | 0 | 1 | 0 | €309.20 | €295.60 | -4.400% |